Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Diastolic Dysfunction Should Be Considered in TAVR

Aortic stenosis increases afterload creating hypertrophy as a compensation mechanism to maintain minute volume. This leads to left ventricular diastolic dysfunction (LVDD).

Hay que considerar la falla diastólica en el TAVIMore than half of patients presenting aortic stenosis have LVDD and myocardial fibrosis, which is a mortality predictor in surgery.

 

At present, there is contradicting evidence in TAVR.

 

The study looked into 777 consecutive patients undergoing TAVR. 545 (70%) presented LVDD: grade I, 98 (18%); grade II, 198 (36.3%); and grade III, 104 (19.1%). 145 patients (26.6%) were excluded for LVDD grade discrepancies.


Read also: Delayed Coronary Obstruction After TAVR: A Complication We Had Not Considered.


Even though populations were similar, patients presenting LVDD were mostly men and had more history of prior AMI and CABG. The higher the LVDD grade, the higher the risk score, with more symptoms and increased BNP.

 

There were no differences in aortic valve area, but there was lower ejection fraction in those presenting LVDD, more concomitant mitral or tricuspid regurgitation and altered ventricular geometry because of associated eccentric hypertrophy.

 

At one year, all-cause mortality was higher in patients with LVDD, which was twice as high in patients presenting grade I; 2.5 times higher in grade II patients and 4 times higher in grade III patients. This last group also saw higher mortality at 30 days.


Read also: Reverse Myocardial Remodeling Following Valve Replacement.


Mortality was driven by cardiac mortality. There were no differences in AMI or stroke. Mortality was not associated to ejection fraction, ventricular mass index, minute volume or the presence of major to mild leak.

 

Mortality predictors at one year were: LVDD (grades I, II, III), BMI ≤20 Kg/m2, diabetes, COPD and peripheral vascular disease.

 

Conclusion

Advanced stages of LVDD after TVR are associated with increased risk of all-cause mortality driven by cardiovascular death, starting within the first 30 days.

 

Comment

The presence of LVDD is very frequent in low functional class patients with severe aortic stenosis. This is associated with a strong negative impact in the short term.

 

It might be necessary to treat these patients before they develop this condition, which would reduce mortality (especially cardiovascular). In fact, we might have to decide before symptoms appear in low functional class patients, or after eco-Doppler findings.

 

Courtesy of Dr. Carlos Fava.

 

Original title: The Impact of Left Ventricular Diastolic Dysfunction on Clinical After Trancatheter Aortic Valve Replacement

Reference: Masahiko Asami, et al. J Am Coll Cardiol Interv 2018;11:593-601


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...